CervoMed Inc. - Common Stock — 현금 흐름 (NASDAQ:CRVO) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

영업활동으로 인한 현금 -13.55 M-14.5 M-14.97 M-7.45 M-16.53 M-23.45 M -27.57 M 투자 활동으로 인한 현금 —4 000-12.24 M—-28.66 M18.1 M 20.41 M 재무활동으로 인한 현금 17.89 M33.3 M5 00011.15 M46.4 M4.59 M 4.6 M 잉여 현금 흐름 -13.55 M-14.5 M-14.97 M-7.45 M-16.53 M-23.45 M -27.57 M

뉴스

Pelthos Therapeutics Inc. (PTHS) Reports Q1 Loss, Beats Revenue Estimates

Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates

IDEAYA Biosciences, Inc. (IDYA) Reports Q1 Loss, Misses Revenue Estimates

H.C. 웨인라이트, CervoMed에 ’매수’ 등급 재확인

H.C. Wainwright reiterates CervoMed stock rating on conference data

CervoMed Inc. (CRVO) Reports Q4 Loss, Lags Revenue Estimates

Buy 2 ‘Strong Buy’ Biotech Stocks With 400%+ Upside, According to Wall Street - TipRanks.com

서보메드, 3상 치매 임상시험에 50mg 용량 설정

CervoMed sets 50mg dose for phase 3 dementia trial

Pharming Group Gears Up to Report Q4 Earnings: What's in the Cards?

CervoMed, UK ALS 임상 플랫폼에 ’neflamapimod’ 선정

CervoMed’s neflamapimod selected for UK ALS trial platform